News Focus
News Focus
Post# of 257437
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: jbog post# 250507

Monday, 02/05/2024 11:01:20 AM

Monday, February 05, 2024 11:01:20 AM

Post# of 257437

…Catalent has been acting more like Hospira than Lonza. Not a prime group at this time.

NVO can’t afford to be choosy. They need more production capacity for Wegovy in order to meet demand (#msg-173623535).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today